Daejeon, South Korea

Jae Seok Lim

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2017-2025

Loading Chart...
Loading Chart...
2 patents (USPTO):

Title: Innovations by Jae Seok Lim

Introduction

Jae Seok Lim is a notable inventor based in Daejeon, South Korea. He has made significant contributions to the field of medical research, particularly in the area of epilepsy treatment. With a total of 2 patents, his work focuses on innovative solutions for intractable epilepsy.

Latest Patents

One of his latest patents is titled "Composition for prevention or treatment of intractable epilepsy comprising mTOR inhibitor." This invention provides a method for the prophylaxis, amelioration, or therapy of intractable epilepsy, including conditions such as Focal Cortical Dysplasia (FCD). Another significant patent is "Animal model for epilepsy and method for producing the same." This invention relates to a technique for inducing epilepsy and creating a non-human animal model of epilepsy, which is crucial for further research and development in this area.

Career Highlights

Jae Seok Lim has worked with prestigious institutions such as the Korea Advanced Institute of Science and Technology and Yonsei University. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Some of his notable coworkers include Jeong Ho Lee and Dong Seok Kim. Their collaborative efforts have further advanced the research and development of innovative solutions in the medical field.

Conclusion

Jae Seok Lim's contributions to the field of epilepsy research through his patents and collaborations highlight his commitment to innovation and improving patient outcomes. His work continues to inspire advancements in medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…